Choosing between DOACs and VKAs could make a significant impact on patient outcomes, according to new findings published in the Journal of the American College of Cardiology.

A new meta-analysis included data from nearly 400,000 PCI patients treated in the United States, Germany, Japan or Israel. 

However, the popular anti-inflammatory drug was linked to at least one other clinical benefit cardiologists should know about. 

“Patients can safely continue oral intake until the time of the procedure, improving their satisfaction and comfort without adverse events,” researchers wrote.

Increasing the use of intravascular ultrasound when performing lower-extremity revascularization procedures could limit complications and improve patient outcomes, according to new recommendations from several medical societies.

The veteran interventional cardiologist was initially sentenced to five years in prison for healthcare fraud. After multiple appeals and some significant updates, however, he was granted a new trial. 

Yousif Ahmad, MD, spoke with Cardiovascular Business about the latest advances in IVL therapy, including new reimbursement changes for the technology. 

Himanshu Gupta, MD, says the implementation of FFR-CT at his facility has provided significant value. He and his colleagues are even working to explore additional ways the technology can help them improve patient care.